THURSDAY, Sept. 26, 2024 (HealthDay News) — Brain damage that veterans suffered from flying shrapnel has provided a major clue that could lead to better treatment for post-traumatic stress disorder (PTSD), a new study says. Veterans who suffered shrapnel damage connected to their amygdala, the fear center of the brain,Continue Reading

WEDNESDAY, Sept. 25, 2024 (HealthDay News) — Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options, new research shows. The two symptoms — blurred vision and sphincter dysfunction of the bladder and/orContinue Reading

THURSDAY, Sept 19, 2024 (HealthDay News) — Exercise, whether moderate- or high-intensity, can help ease Parkinson’s symptoms, including fatigue, new research shows. As study lead author Dr. Philip Millar explained, Parkinson’s patients are too often overwhelmed by shame or depression, so they stop going to the gym or exercising. That’sContinue Reading

THURSDAY, Sept. 19, 2024 (HealthDay News) — A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream andContinue Reading

 WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent or potentially cure paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to moreContinue Reading